Home Healthcare Pharmaceuticals Insulin Glargine Market

Insulin Glargine Market Size, Share & Trends Analysis Report By Product (Branded Insulin Glargine, Lantus, Basaglar, Toujeo, Other Brand, Glargine Biosimilars), By Application (Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 07, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Insulin Glargine Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Branded Insulin Glargine
    2. Lantus
    3. Basaglar
    4. Toujeo
    5. Other Brand
    6. Glargine Biosimilars
  2. Insulin Glargine Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Type 1 Diabetes
    2. Type 2 Diabetes
  3. Insulin Glargine Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  4. Regional Insulin Glargine Market
    1. North America
      1. North America Insulin Glargine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
      2. North America Insulin Glargine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. North America Insulin Glargine Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.S.
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Canada
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    2. Europe
      1. Europe Insulin Glargine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
      2. Europe Insulin Glargine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. Europe Insulin Glargine Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.K.
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Germany
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. France
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. Spain
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Italy
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Russia
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Nordic
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      11. Benelux
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      12. Rest of Europe
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    3. APAC
      1. APAC Insulin Glargine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
      2. APAC Insulin Glargine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. APAC Insulin Glargine Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. China
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Korea
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Japan
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. India
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Australia
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Singapore
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Taiwan
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      11. South East Asia
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      12. Rest of Asia-Pacific
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Insulin Glargine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
      2. Middle East and Africa Insulin Glargine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. Middle East and Africa Insulin Glargine Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. UAE
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Turkey
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Saudi Arabia
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. South Africa
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Egypt
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Nigeria
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Rest of MEA
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    5. LATAM
      1. LATAM Insulin Glargine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
      2. LATAM Insulin Glargine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. LATAM Insulin Glargine Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Brazil
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Mexico
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Argentina
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. Chile
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Colombia
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Rest of LATAM
        1. Branded Insulin Glargine
        2. Lantus
        3. Basaglar
        4. Toujeo
        5. Other Brand
        6. Glargine Biosimilars
        7. Type 1 Diabetes
        8. Type 2 Diabetes
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.